The expression of DNMT1 resulted significantly reduced in CLL cells compared with HD B cells, reflecting the lower methylation levels within the CAT promoter shown by CLL versus HD B cells. This evidence concerns the gene DNMT1 and B-cell chronic lymphocytic leukemia.